Symbol
| SPRED2
| contributors: mct - updated : 24-11-2021
|
HGNC name
| sprouty-related, EVH1 domain containing 2
|
HGNC id
| 17722
|
corresponding disease(s)
|
NNL4
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
impairs autophagy, leading to cardiac dysfunction and life-threatening arrhythmias | |
Susceptibility
|
to rheumatoid arthritis (RA) |
Variant & Polymorphism
other
| SPRED2 is an RA-susceptibility gene |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
immunology | inflammatory | | |
SPRED2 may be a new therapeutic target for the treatment of ulcerative colitis (UC) |
| | | |
| loss of Spred-2 inhibits bone growth by inhibiting chondrocyte differentiation through up-regulation of the MAPK signaling pathway | |
Spred2(-/-) mice exhibit dwarfism and increase of early haematopoiesis |
|
Spred2-/-mice were reported to have a markedly reduced growth and shorter long bones,54 cardiac fibrosis and arrhythmias, and a shortened lifespan |
|
|